We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · September 26, 2022

Plasma SARS-CoV-2 Nucleocapsid Antigen Levels Are Associated With Progression to Severe Disease in Patients Hospitalized With COVID-19

Critical Care (London, England)


Additional Info

Critical Care (London, England)
Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19
Crit Care 2022 Sep 14;26(1)278, KD Wick, A Leligdowicz, A Willmore, SA Carrillo, R Ghale, A Jauregui, SS Chak, V Nguyen, D Lee, C Jones, R Dewar, HC Lane, KN Kangelaris, CM Hendrickson, KD Liu, P Sinha, DJ Erle, CR Langelier, MF Krummell, PG Woodruff, CS Calfee, MA Matthay

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading